Correlation Between OSE Pharma and Biomerieux

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OSE Pharma and Biomerieux at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OSE Pharma and Biomerieux into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OSE Pharma SA and Biomerieux SA, you can compare the effects of market volatilities on OSE Pharma and Biomerieux and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OSE Pharma with a short position of Biomerieux. Check out your portfolio center. Please also check ongoing floating volatility patterns of OSE Pharma and Biomerieux.

Diversification Opportunities for OSE Pharma and Biomerieux

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between OSE and Biomerieux is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding OSE Pharma SA and Biomerieux SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomerieux SA and OSE Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OSE Pharma SA are associated (or correlated) with Biomerieux. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomerieux SA has no effect on the direction of OSE Pharma i.e., OSE Pharma and Biomerieux go up and down completely randomly.

Pair Corralation between OSE Pharma and Biomerieux

Assuming the 90 days trading horizon OSE Pharma SA is expected to generate 4.12 times more return on investment than Biomerieux. However, OSE Pharma is 4.12 times more volatile than Biomerieux SA. It trades about 0.06 of its potential returns per unit of risk. Biomerieux SA is currently generating about 0.02 per unit of risk. If you would invest  374.00  in OSE Pharma SA on August 27, 2024 and sell it today you would earn a total of  515.00  from holding OSE Pharma SA or generate 137.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

OSE Pharma SA  vs.  Biomerieux SA

 Performance 
       Timeline  
OSE Pharma SA 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OSE Pharma SA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, OSE Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Biomerieux SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomerieux SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Biomerieux is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

OSE Pharma and Biomerieux Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OSE Pharma and Biomerieux

The main advantage of trading using opposite OSE Pharma and Biomerieux positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OSE Pharma position performs unexpectedly, Biomerieux can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomerieux will offset losses from the drop in Biomerieux's long position.
The idea behind OSE Pharma SA and Biomerieux SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios